Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Rocuronium Bromide Injection had an annual sale of approximately US $53 million in the US (IQVIA MAT December 2022)
Merck and Ridgeback will appeal the decision and request a re-examination of the CHMP’s opinion.
The safety profile of LAGEVRIO in this trial was generally consistent with that observed in previously reported clinical studies
It is administered as a single infusion 30 minutes prior to the start of each chemotherapy cycle that helps prevent, both, acute and delayed phases of CINV
Viehbacher brings extensive international experience in large pharmaceutical and entrepreneurial biotech companies
Sud has more than 32 years of work experience with different companies like Clivient, Jubilant Life Sciences, Piramal Enterprises, Parabolic Drugs, Orchid Chemicals and Pharmaceuticals, Ranbaxy Labs, and Lupin
Subscribe To Our Newsletter & Stay Updated
